UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000034757
Receipt No. R000039638
Official scientific title of the study Phase II trial of pembrolizumab as first-line therapy for advanced non-small cell lung cancer with high PD-L1 expression in patients with poor performance status 1801.
Date of disclosure of the study information 2018/11/03
Last modified on 2018/11/03 14:48:57

No. Disposal Last modified on Item of update
1 Insert 2018/11/03 14:49:18


Contact us.